Question 1

Has Melissa Motes received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $12,625 in general payments to Melissa Motes across 702 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Melissa Motes did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Melissa Motes come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
AbbVie	145	$1,855
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	51	$1,043
Axsome Therapeutics, Inc.	43	$895
Otsuka America Pharmaceutical, Inc.	46	$878
Alkermes, Inc.	35	$872
Lundbeck LLC	29	$569
Corium, LLC	40	$551
Almatica Pharma LLC	30	$471
Takeda Pharmaceuticals U.S.A., Inc.	24	$466
Bausch Health US, LLC	23	$436
AstraZeneca	10	$421
Vanda Pharmaceuticals Inc.	19	$399
Teva Pharmaceuticals USA, Inc.	25	$365
Boehringer Ingelheim	15	$346
Neos Therapeutics, LP	17	$307
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	13	$288
Ironshore Pharmaceuticals Inc.	13	$272
Johnson & Johnson	14	$247
GSK	17	$230
Tris Pharma Inc	10	$193
Amgen	9	$161
Daiichi Sankyo Inc.	4	$152
Supernus Pharmaceuticals, Inc.	10	$127
Lilly USA, LLC	9	$127
Noven Therapeutics, LLC	6	$125
Ironwood Pharmaceuticals, Inc	6	$102
Novo Nordisk	8	$100
Astellas Pharma US Inc	1	$99
Novartis	6	$95
Pfizer	5	$79
Idorsia Pharmaceuticals US Inc	4	$71
Merck	4	$66
Medtronic	2	$36
Dexcom, Inc.	1	$35
Esperion Therapeutics, Inc.	2	$30
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$28
E.r. Squibb & Sons, L.L.C.	1	$24
Collegium Pharmaceutical, Inc.	1	$21
Sanofi-aventis U.S. LLC	1	$15
Ultragenyx Pharmaceutical Inc.	1	$14
Neurocrine Biosciences, Inc.	1	$13

Melissa Motes

Payments from drug & device makers

Who reported the general payments

How this compares

Other family in Greenville